Selectivity and Safety of VIP943: A Novel CD123-Targeting Antibody-Drug Conjugate (ADC) Using a Proprietary Linker and Payload Class

被引：2
|
作者：
Stelte-Ludwig, Beatrix [1 ]
Schomber, Tibor [1 ]
Izumi, Raquel [2 ]
Wong, Harvey [2 ]
Frigault, Melanie M. [2 ]
Rebstock, Anne-Sophie [1 ]
Ludwig, Sebastian [1 ]
Mithal, Arushi [2 ]
Johnson, Amy J. [2 ]
Hamdy, Ahmed [2 ]
机构：
[1] Vincerx Pharma GmbH, Monheim, Germany
[2] Vincerx Pharma, Palo Alto, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-182260
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 36 条
  • [21] In vitro and in vivo activity of a novel c-Met-targeting antibody-drug conjugate using a DNA-alkylating, indolinobenzodiazepine payload
    Lai, Katharine C.
    Muvaffak, Asli
    Li, Min
    Themeles, Marian
    Sikka, Surina
    Donahue, Kerry
    Hicks, Stuart W.
    Romanelli, Angela
    Chittenden, Thomas
    CANCER RESEARCH, 2017, 77
  • [22] Combining IMGN632, a Novel CD123-Targeting Antibody Drug Conjugate with Azacitidine and Venetoclax Facilitates Apoptosis in Vitro and Prolongs Survival In Vivo in AML Models
    Kuruvilla, Vinitha Mary
    Zhang, Qi
    Daver, Naval
    Watkins, Krystal
    Sloss, Callum M.
    Zweidler-McKay, Patrick A.
    Romanelli, Angela
    Konopleva, Marina
    BLOOD, 2020, 136
  • [23] A phase I/II study of IMGN632, a novel CD123-targeting antibody-drug conjugate, in patients with relapsed/refractory acute myeloid leukemia, blastic plasmacytoid dendritic cell neoplasm, and other CD123-positive hematologic malignancies.
    Daver, Naval Guastad
    Montesinos, Pau
    DeAngelo, Daniel J.
    Wang, Eunice S.
    Todisco, Elisabetta
    Tarella, Corrado
    Martinelli, Giovanni
    Erba, Harry Paul
    Deconinck, Eric
    Sweet, Kendra L.
    Walter, Roland B.
    Levy, Moshe Yair
    Pemmaraju, Naveen
    Lane, Andrew A.
    Rizzieri, David
    Konopleva, Marina
    Sloss, Callum Mortimer
    Wang, Jiuzhou
    Malcolm, Kara E.
    Zweidler-McKay, Patrick A.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [24] Characterization and preclinical development of STRO-001, a novel CD74-targeting antibody-drug conjugate (ADC) for the treatment of B-cell malignancies
    Abrahams, Cristina
    Li, Xiaofan
    DeAlmeida, Venita
    Embry, Millicent
    Yu, Abigail
    Krim, Stellanie
    Hoffmann, Heidi
    Zawada, James
    Bruhns, Maureen
    Matheny, Shannon
    Bussell, Stuart
    Kline, Toni
    Yam, Alice
    Stafford, Ryan
    Hallam, Trevor
    Lupher, Mark
    Molina, Arturo
    CANCER RESEARCH, 2017, 77
  • [25] Preclinical efficacy studies using HuMax-Axl-ADC, a novel antibody-drug conjugate targeting Axl-expressing solid cancers.
    Breij, Esther C. W.
    Verploegen, Sandra
    Lingnau, Andreas
    van den Brink, Edward N.
    Janmaat, Maarten
    Houtkamp, Mischa
    Bleeker, Wim
    Satijn, David
    Parren, Paul
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] SGN-CD33A: a novel CD33-targeting antibody-drug conjugate using a pyrrolobenzodiazepine dimer is active in models of drug-resistant AML
    Sutherland, May S. Kung
    Walter, Roland B.
    Jeffrey, Scott C.
    Burke, Patrick J.
    Yu, Changpu
    Kostner, Heather
    Stone, Ivan
    Ryan, Maureen C.
    Sussman, Django
    Lyon, Robert P.
    Zeng, Weiping
    Harrington, Kimberly H.
    Klussman, Kerry
    Westendorf, Lori
    Meyer, David
    Bernstein, Irwin D.
    Senter, Peter D.
    Benjamin, Dennis R.
    Drachman, Jonathan G.
    McEarchern, Julie A.
    BLOOD, 2013, 122 (08) : 1455 - 1463
  • [27] IMGN529, a Novel Antibody-Drug Conjugate (ADC) Targeting CD37 Shows Synergistic Activity with Rituximab in Non-Hodgkin Lymphoma (NHL) Models
    Deckert, Jutta
    Sloss, Callum M.
    O'Callaghan, Katie
    Tsui, Jenny
    Dawra, Nemisha
    Yi, Yong
    Coccia, Jennifer A.
    Lanieri, Leanne
    Chicklas, Sharon
    Romanelli, Angela
    BLOOD, 2015, 126 (23)
  • [28] A novel pegylated bispecific antibody-drug conjugate (P-BsADCpb-adc) targeting cancers co-expressing PD-L1 and CD47
    Liu, Shumin
    Lyu, Weidong
    Yin, Shuqiang
    Lei, Yang
    Zhuo, Qiudong
    Zheng, Liling
    Sun, Bin
    Tan, Shuangyu
    Jiang, Lidong
    Zhang, Teng
    Gao, Bo
    Xu, Rui
    Huang, Dechang
    Li, Yong
    Wu, Zibin
    Wu, David
    Wen, Yvonne Yu
    CANCER RESEARCH, 2023, 83 (07)
  • [29] Characterization of the mechanism of action, pharmacodynamics and preclinical safety of ADCT-402, a pyrrolobenzodiazepine (PBD) dimer-containing antibody-drug conjugate (ADC) targeting CD19-expressing hematological malignancies
    Zammarchi, Francesca
    Corbett, Simon
    Havenith, Karin
    Janghra, Narinder
    Kiakos, Konstantinos
    Marafioti, Teresa
    Williams, David G.
    Chivers, Simon
    Howard, Phil W.
    Hartley, John A.
    van Berkel, Patrick H.
    CANCER RESEARCH, 2017, 77
  • [30] HMA800067, a novel CD38-targeting antibody-drug conjugate (ADC), demonstrated superior anti-tumor activity to daratumumab in preclinical B-cell malignancies models
    Xu, Yan
    Liang, Junqing
    Jiang, Shuwen
    Yang, Haibin
    Zhang, Hui
    Mao, Fangfang
    Zhu, Jiahuan
    He, Jianlin
    Yang, Na
    Wang, Jian
    Zhang, WeiHan
    Ren, Yongxin
    Su, Weiguo
    CANCER RESEARCH, 2024, 84 (06)
1234